Tempest Therapeutics

#药闻简讯# 2025 年 11 月 19 日——为了扩大其产品线并延长其运营资金，临床阶段生物技术公司$Tempest Therapeutics(TPST)$ 今天宣布已与 Factor Bioscience Inc.及其附属公司（统称为“Factor”）达成最终协议，以全股票交易方式收购某些双靶向嵌合抗原受体（CAR）-T 项目（“拟议交易”）。拟议...

$Tempest Therapeutics(TPST)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001127430-26-000002  Size: 5 KB 网页链接

$Tempest Therapeutics(TPST)$ DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material Accession Number: 0001193125-25-287188  Act: 34  Size: 567 KB 网页链接

$Tempest Therapeutics(TPST)$ 424B5 Prospectus [Rule 424(b)(5)] Accession Number: 0001193125-25-294736  Act: 33  Size: 538 KB 网页链接

$Tempest Therapeutics(TPST)$ 8-K Current report, items 3.02, 8.01, and 9.01 Accession Number: 0001193125-25-298604  Act: 34  Size: 713 KB 网页链接

$Tempest Therapeutics(TPST)$ SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors Accession Number: 0001535610-26-000017  Act: 34  Size: 9 KB 网页链接

$Tempest Therapeutics(TPST)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001871563-26-000002  Size: 5 KB 网页链接

$Tempest Therapeutics(TPST)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001931356-26-000006  Size: 5 KB 网页链接

$Tempest Therapeutics(TPST)$ PRE 14A Other preliminary proxy statements Accession Number: 0001140361-25-043939  Act: 34  Size: 7 MB 网页链接

$Tempest Therapeutics(TPST)$ ARS Annual Report to Security Holders Accession Number: 0001140361-25-047055  Act: 34  Size: 2 MB 网页链接

$Tempest Therapeutics(TPST)$ 8-K Current report, item 3.01 Accession Number: 0001193125-26-008938  Act: 34  Size: 174 KB 网页链接

$Tempest Therapeutics(TPST)$ 8-K Current report, items 1.01, 2.01, 3.02, 5.01, 5.02, and 9.01 Accession Number: 0001193125-26-041190  Act: 34  Size: 609 KB 网页链接

$Tempest Therapeutics(TPST)$ 8-K Current report, items 1.01, 3.02, 5.02, 8.01, and 9.01 Accession Number: 0001193125-25-287163  Act: 34  Size: 888 KB 网页链接

$Tempest Therapeutics(TPST)$ 本文件详细说明了SABBY MANAGEMENT, LLC、Sabby Volatility Warrant Master Fund, Ltd.以及Hal Mintz对Tempest Therapeutics, Inc.普通股的实益所有权。截至2025年12月31日，这些实体共同持有492,223股，占该类别股份的9.9%。他们对这些股份拥有共同的投票权和处置权...

$Tempest Therapeutics(TPST)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001214505-26-000003  Size: 5 KB 网页链接

$Tempest Therapeutics(TPST)$ S-1 General form for registration of securities under the Securities Act of 1933 Accession Number: 0001193125-25-312887  Act: 33  Size: 441 KB 网页链接

$Tempest Therapeutics(TPST)$ EFFECT Notice of Effectiveness Accession Number: 9999999995-26-000019  Act: 33  Size: 1 KB 网页链接

$Tempest Therapeutics(TPST)$ DEF 14A Other definitive proxy statements Accession Number: 0001140361-25-047054  Act: 34  Size: 7 MB 网页链接

$Tempest Therapeutics(TPST)$ 8-K Current report, items 3.03, 5.02, and 5.07 Accession Number: 0001193125-26-027203  Act: 34  Size: 195 KB 网页链接

$Tempest Therapeutics(TPST)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001321402-26-000003  Size: 5 KB 网页链接